vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
AMERICAN SUPERCONDUCTOR CORP is the larger business by last-quarter revenue ($74.5M vs $57.3M, roughly 1.3× RHYTHM PHARMACEUTICALS, INC.). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs -83.0%, a 241.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 21.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 33.2%).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
AMSC vs RYTM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $57.3M |
| Net Profit | $117.8M | $-47.5M |
| Gross Margin | 30.7% | 91.6% |
| Operating Margin | 4.5% | -82.2% |
| Net Margin | 158.1% | -83.0% |
| Revenue YoY | 21.4% | 36.9% |
| Net Profit YoY | 4679.1% | -9.6% |
| EPS (diluted) | $2.62 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | $57.3M | ||
| Q3 25 | $65.9M | $51.3M | ||
| Q2 25 | $72.4M | $48.5M | ||
| Q1 25 | $66.7M | $32.7M | ||
| Q4 24 | $61.4M | $41.8M | ||
| Q3 24 | $54.5M | $33.3M | ||
| Q2 24 | $40.3M | $29.1M | ||
| Q1 24 | $42.0M | $26.0M |
| Q4 25 | $117.8M | $-47.5M | ||
| Q3 25 | $4.8M | $-52.9M | ||
| Q2 25 | $6.7M | $-46.6M | ||
| Q1 25 | $1.2M | $-49.5M | ||
| Q4 24 | $2.5M | $-43.3M | ||
| Q3 24 | $4.9M | $-43.6M | ||
| Q2 24 | $-2.5M | $-32.3M | ||
| Q1 24 | $-1.6M | $-141.4M |
| Q4 25 | 30.7% | 91.6% | ||
| Q3 25 | 31.0% | 89.3% | ||
| Q2 25 | 33.8% | 88.6% | ||
| Q1 25 | 26.5% | 88.8% | ||
| Q4 24 | 26.6% | 90.9% | ||
| Q3 24 | 28.7% | 88.5% | ||
| Q2 24 | 30.3% | 89.9% | ||
| Q1 24 | 24.8% | 89.2% |
| Q4 25 | 4.5% | -82.2% | ||
| Q3 25 | 4.5% | -102.6% | ||
| Q2 25 | 7.8% | -93.4% | ||
| Q1 25 | 2.5% | -143.7% | ||
| Q4 24 | 2.1% | -98.6% | ||
| Q3 24 | -1.4% | -132.0% | ||
| Q2 24 | -8.2% | -139.2% | ||
| Q1 24 | -5.3% | -538.7% |
| Q4 25 | 158.1% | -83.0% | ||
| Q3 25 | 7.2% | -103.1% | ||
| Q2 25 | 9.3% | -96.1% | ||
| Q1 25 | 1.8% | -151.4% | ||
| Q4 24 | 4.0% | -103.6% | ||
| Q3 24 | 9.0% | -131.2% | ||
| Q2 24 | -6.3% | -110.9% | ||
| Q1 24 | -3.8% | -544.4% |
| Q4 25 | $2.62 | $-0.73 | ||
| Q3 25 | $0.11 | $-0.82 | ||
| Q2 25 | $0.17 | $-0.75 | ||
| Q1 25 | $0.04 | $-0.81 | ||
| Q4 24 | $0.06 | $-0.71 | ||
| Q3 24 | $0.13 | $-0.73 | ||
| Q2 24 | $-0.07 | $-0.55 | ||
| Q1 24 | $-0.03 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $536.8M | $139.1M |
| Total Assets | $719.5M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $388.9M | ||
| Q3 25 | $212.9M | $416.1M | ||
| Q2 25 | $207.9M | $291.0M | ||
| Q1 25 | $79.5M | $314.5M | ||
| Q4 24 | $75.2M | $320.6M | ||
| Q3 24 | $72.1M | $298.4M | ||
| Q2 24 | $93.5M | $319.1M | ||
| Q1 24 | $90.5M | $201.2M |
| Q4 25 | $536.8M | $139.1M | ||
| Q3 25 | $342.2M | $148.8M | ||
| Q2 25 | $333.1M | $-11.9M | ||
| Q1 25 | $197.1M | $18.9M | ||
| Q4 24 | $192.7M | $21.7M | ||
| Q3 24 | $187.0M | $11.2M | ||
| Q2 24 | $143.3M | $39.3M | ||
| Q1 24 | $144.6M | $61.6M |
| Q4 25 | $719.5M | $480.2M | ||
| Q3 25 | $445.6M | $506.9M | ||
| Q2 25 | $452.8M | $372.7M | ||
| Q1 25 | $310.5M | $386.7M | ||
| Q4 24 | $310.3M | $392.3M | ||
| Q3 24 | $298.4M | $363.6M | ||
| Q2 24 | $240.1M | $381.8M | ||
| Q1 24 | $232.8M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $-25.4M |
| Free Cash FlowOCF − Capex | $2.4M | — |
| FCF MarginFCF / Revenue | 3.2% | — |
| Capex IntensityCapex / Revenue | 1.2% | — |
| Cash ConversionOCF / Net Profit | 0.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $-25.4M | ||
| Q3 25 | $6.5M | $-26.6M | ||
| Q2 25 | $4.1M | $-23.3M | ||
| Q1 25 | $6.3M | $-40.4M | ||
| Q4 24 | $5.9M | $-18.8M | ||
| Q3 24 | $12.7M | $-25.2M | ||
| Q2 24 | $3.4M | $-29.1M | ||
| Q1 24 | $2.2M | $-40.7M |
| Q4 25 | $2.4M | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $5.3M | — | ||
| Q3 24 | $12.1M | — | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $1.9M | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 4.6% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
RYTM
Segment breakdown not available.
